SUBSCRIBE
SUBSCRIBE
News   Business

Virbac Corporation Exercises Its Options for a Commercial Licence Agreement to Use Vivalis’ EBx(R) Platform

April 1, 2008 | 
1 min read
NANTES, FRANCE--(Marketwire - April 01, 2008) - Highlighted Links VIRBAC EXERCISES ITS OPTION FOR A COMMERCIAL LICENCE AGREEMENT TO USE VIVALIS' EBx® PLATFORM FOR THE PRODUCTION OF SEVERAL VACCINES.
Alliances Europe
MORE ON THIS TOPIC
Closeup of businessman give money to robot. Man pass banknote bribe to robotic assistant. AI and technology. Vector illustration.
Immunology and inflammation
Novartis Unites With Relation in $1.7B Inflammatory Skin Disease Pact
December 9, 2025
 · 
2 min read
 · 
Tristan Manalac
Poznan, Poland – October 29, 2020: The Glaxosmithkline headquarters office building in Poznan. LOGO. GaxoSmithKline also called GSK is a British pharmaceutical company.
Cancer
GSK Cuts Five-Year-Old Cancer Collaboration With Ideaya
December 8, 2025
 · 
2 min read
 · 
Tristan Manalac
Business people shaking hand in China.
Collaboration
Crescent, Kelun-Biotech Swap Therapies in ADC-Bispecific Deal Worth Up To $1.25B
December 4, 2025
 · 
2 min read
 · 
Tristan Manalac
Tariff Trade Disaster and drowning with economic tariffs and market crash anxiety with government taxation or duties imposed on imports and exports on imported or exported goods as Protectionism.
Opinion
Even Early Stage Biotechs Can’t Ignore Tariffs
December 3, 2025
 · 
4 min read
 · 
Josh Medow